Thomas Woiwode

Thomas Woiwode, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Tempest Therapeutics, Inc., Aligos Therapeutics, Inc. and Gritstone bio, Inc. The record holds 4 filings, for trades running from 11 June 2021 to 29 April 2022.

Every open-market trade on record is a purchase: 1 purchase worth €4.8M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. 2022 to date brings 1 purchase and no sales.

The newest entry dates from 3 May 2022: an open-market purchase of €4.8M, in Tempest Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.